CS logo
small CS logo
Clinica De Enfermedades Cronicas y Procedimientos Especiales

Morelia, Michoacan, Mexico
Doctor in Morelia
C. Nicolás Bravo 1734, Villa Universidad, 58060 Morelia, Mich.

About Clinica De Enfermedades Cronicas y Procedimientos Especiales


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
8
Pfizer
4
EMD Serono
1
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
1
Total Rows: 4

Clinical Trials at Clinica De Enfermedades Cronicas y Procedimientos Especiales


During the past decade, Clinica De Enfermedades Cronicas y Procedimientos Especiales conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 9 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1144222211110022Started TrialsCompleted Trails20172018201920200246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
2007-02-05
2017-10-26
Completed
4,488
A Study To Evaluate The Efficacy And Safety Of Varenicline Compared To Placebo For Smoking Cessation Through Reduction
2011-07-01
2013-07-01
Completed
1,510
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
2011-11-01
2015-01-01
Completed
8,144
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
2013-12-01
2016-09-01
Completed
306
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
2014-03-14
2020-07-22
Completed
4,372
A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis
2017-11-23
2019-08-16
Completed
660
A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis
2018-03-28
2023-08-07
Active, not recruiting
1,645
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
2018-03-14
2026-11-30
Recruiting
325

Rows per page:

1–14 of 14

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica De Enfermedades Cronicas y Procedimientos Especiales" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEli Lilly and Company: 8Eli Lilly and Company: 8Pfizer: 4Pfizer: 4EMD Serono: 1EMD Serono: 1Merck Healthcare KGaA,Darmstadt, Germany,an affiliate of MerckKGaA, Darmstadt,Germany: 1Merck Healthcare KGaA,Darmstadt, Germany,an affiliate of MerckKGaA, Darmstadt,Germany: 1

Created with Highcharts 11.1.0Top CollaboratorsDermira, Inc.: 2Dermira, Inc.: 2Incyte Corporation: 2Incyte Corporation: 2GlaxoSmithKline: 1GlaxoSmithKline: 1

Clinical Trials Conditions at Clinica De Enfermedades Cronicas y Procedimientos Especiales


According to Clinical.Site data, the most researched conditions in "Clinica De Enfermedades Cronicas y Procedimientos Especiales" are "Atopic Dermatitis" (4 trials), "Arthritis, Rheumatoid" (2 trials), "Psoriasis" (2 trials), "Smoking Cessation" (2 trials) and "Chronic Migraine" (1 trials). Many other conditions were trialed in "Clinica De Enfermedades Cronicas y Procedimientos Especiales" in a lesser frequency.

Clinical Trials Intervention Types at Clinica De Enfermedades Cronicas y Procedimientos Especiales


Most popular intervention types in "Clinica De Enfermedades Cronicas y Procedimientos Especiales" are "Drug" (12 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Baricitinib" (2 trials), "Galcanezumab" (2 trials), "Lebrikizumab" (2 trials) and "Mirikizumab" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Clinica De Enfermedades Cronicas y Procedimientos Especiales


The vast majority of trials in "Clinica De Enfermedades Cronicas y Procedimientos Especiales" are 14 trials for "All" genders.

Clinical Trials Status at Clinica De Enfermedades Cronicas y Procedimientos Especiales


Currently, there are NaN active trials in "Clinica De Enfermedades Cronicas y Procedimientos Especiales". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Clinica De Enfermedades Cronicas y Procedimientos Especiales, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Clinica De Enfermedades Cronicas y Procedimientos Especiales, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 9Phase 3: 9Phase 4: 3Phase 4: 3Phase 1: 1Phase 1: 1Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 9Completed: 9Active, not recruiting: 2Active, not recruiting: 2Recruiting: 2Recruiting: 2Terminated: 1Terminated: 1